Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 3
2008 1
2009 2
2011 1
2012 4
2013 3
2014 3
2015 4
2016 3
2017 8
2018 3
2019 11
2020 5
2021 4
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Sex disparities matter in cancer development and therapy.
Haupt S, Caramia F, Klein SL, Rubin JB, Haupt Y. Haupt S, et al. Nat Rev Cancer. 2021 Jun;21(6):393-407. doi: 10.1038/s41568-021-00348-y. Epub 2021 Apr 20. Nat Rev Cancer. 2021. PMID: 33879867 Free PMC article. Review.
Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction.
Fujihara KM, Zhang BZ, Jackson TD, Ogunkola MO, Nijagal B, Milne JV, Sallman DA, Ang CS, Nikolic I, Kearney CJ, Hogg SJ, Cabalag CS, Sutton VR, Watt S, Fujihara AT, Trapani JA, Simpson KJ, Stojanovski D, Leimkühler S, Haupt S, Phillips WA, Clemons NJ. Fujihara KM, et al. Among authors: haupt s. Sci Adv. 2022 Sep 16;8(37):eabm9427. doi: 10.1126/sciadv.abm9427. Epub 2022 Sep 14. Sci Adv. 2022. PMID: 36103522 Free PMC article.
The long and the short of it: the MDM4 tail so far.
Haupt S, Mejía-Hernández JO, Vijayakumaran R, Keam SP, Haupt Y. Haupt S, et al. J Mol Cell Biol. 2019 Mar 1;11(3):231-244. doi: 10.1093/jmcb/mjz007. J Mol Cell Biol. 2019. PMID: 30689920 Free PMC article. Review.
Clinical Overview of MDM2/X-Targeted Therapies.
Burgess A, Chia KM, Haupt S, Thomas D, Haupt Y, Lim E. Burgess A, et al. Among authors: haupt s. Front Oncol. 2016 Jan 27;6:7. doi: 10.3389/fonc.2016.00007. eCollection 2016. Front Oncol. 2016. PMID: 26858935 Free PMC article. Review.
P53: A Guardian of Immunity Becomes Its Saboteur through Mutation.
Agupitan AD, Neeson P, Williams S, Howitt J, Haupt S, Haupt Y. Agupitan AD, et al. Among authors: haupt s. Int J Mol Sci. 2020 May 13;21(10):3452. doi: 10.3390/ijms21103452. Int J Mol Sci. 2020. PMID: 32414156 Free PMC article. Review.
Regulation of Mutant p53 Protein Expression.
Vijayakumaran R, Tan KH, Miranda PJ, Haupt S, Haupt Y. Vijayakumaran R, et al. Among authors: haupt s. Front Oncol. 2015 Dec 17;5:284. doi: 10.3389/fonc.2015.00284. eCollection 2015. Front Oncol. 2015. PMID: 26734569 Free PMC article. Review.
PML tumour suppression and beyond: therapeutic implications.
Gamell C, Jan Paul P, Haupt Y, Haupt S. Gamell C, et al. Among authors: haupt s. FEBS Lett. 2014 Aug 19;588(16):2653-62. doi: 10.1016/j.febslet.2014.02.007. Epub 2014 Feb 15. FEBS Lett. 2014. PMID: 24548562 Free article. Review.
C-Abl as a modulator of p53.
Levav-Cohen Y, Goldberg Z, Zuckerman V, Grossman T, Haupt S, Haupt Y. Levav-Cohen Y, et al. Among authors: haupt s. Biochem Biophys Res Commun. 2005 Jun 10;331(3):737-49. doi: 10.1016/j.bbrc.2005.03.152. Biochem Biophys Res Commun. 2005. PMID: 15865930 Review.
61 results